Aspen Aerogels, Inc. — FY 2016 Form 10-K
Reporting period: Fiscal year ended December 31, 2016. The filing is an annual report, not a standalone fourth-quarter filing; quarterly figures below are included where relevant. Amounts are in U.S. dollars.
Business context
Aspen designs and manufactures aerogel insulation, primarily for energy infrastructure, and earns a small portion of revenue from government and institutional research services. Product revenue represented 98% of 2016 revenue. The company operated three production lines at its East Providence, Rhode Island facility, with estimated annual nameplate capacity of approximately 50 million square feet.
Financial performance and liquidity
| Metric | FY 2016 | FY 2015 |
|---|---|---|
| Total revenue | $117.7 million | $122.5 million |
| Product revenue | $115.5 million | $120.5 million |
| Research services revenue | $2.2 million | $2.0 million |
| Gross profit / margin | $23.3 million / 19.8% | $24.6 million / 20.1% |
| Operating loss | $11.2 million | $6.2 million |
| Net loss | $12.0 million; $0.52 per share | $6.4 million; $0.28 per share |
| Adjusted EBITDA (non-GAAP) | $3.9 million | $9.1 million |
| Cash from operating activities | $(0.6) million | $5.4 million |
| Capital expenditures | $13.2 million | $22.0 million |
| Cash and cash equivalents at year-end | $18.1 million | $32.8 million |
| Working capital at year-end | $32.1 million | $44.2 million |
Product shipments rose 5% to 44.3 million square feet, while average selling price fell 8% to $2.61 per square foot. Management attributed the price decline mainly to a lower mix of higher-priced subsea products and project-based pricing for Reliance Industries. Product material costs declined to 41% of product revenue from 45%, but manufacturing expense increased to 39% from 36% of product revenue. Total operating expenses rose 12% to $34.5 million, including higher patent-enforcement costs.
At December 31, debt consisted of approximately $39,000 in capital leases. The company had no revolver borrowings, but $2.7 million of letters of credit reduced effective availability under its $20 million Silicon Valley Bank facility to $12.1 million. The facility’s maturity was extended to January 28, 2018. Cash declined by $14.7 million during 2016.
Material changes and fourth-quarter results
- Revenue fell 4% year over year, principally due to weaker subsea and European energy-market sales and constrained energy-sector investment; growth in Asia and building materials partly offset the decline.
- Operating loss widened from $6.2 million to $11.2 million as gross profit declined and operating expenses increased. Net loss increased to $12.0 million.
- In the fourth quarter of 2016, revenue was $27.6 million, gross profit $3.7 million, and net loss $5.7 million, compared with fourth-quarter 2015 revenue of $37.4 million, gross profit of $9.9 million, and net income of $1.6 million.
- Inventory increased to $12.9 million from $6.5 million, primarily reflecting finished goods; operating cash flow was negative.
Outlook, risks, and unusual items
- Management projected that 2017 total and product revenue would decline, without providing a specific forecast amount. The expected decline reflects the completion of a major Reliance Industries petrochemical project, which contributed 25% of 2016 product revenue, and continued constrained energy-market investment. Management also expected gross margin to decline and losses to increase, given fixed manufacturing costs.
- The planned Statesboro, Georgia plant was temporarily delayed in late 2016 to align capacity expansion with expected demand for 2018–2020. Estimated infrastructure and first-line cost is $120–$130 million for approximately 40 million square feet of additional annual nameplate capacity. The company had capitalized $7.2 million of related engineering and pre-construction costs.
- BASF’s potential $22 million of non-interest-bearing prepayments are conditional on plant progress and financing requirements, including a third-party debt commitment of at least $30 million. Payments had not begun by year-end; BASF has no minimum purchase obligation, and uncredited amounts may be repayable.
- Reliance Industries and Distribution International accounted for 25% and 15% of 2016 revenue, respectively. The three largest receivables represented 31%, 17%, and 10% of accounts receivable, creating customer and collection concentration risk.
- The company depends on a single manufacturing site and identifies energy-market weakness, premium pricing, raw-material availability, production quality, financing needs, and customer adoption as material risks.
- Patent-enforcement proceedings against Chinese aerogel producers were ongoing in the United States and Germany; the company had incurred approximately $3.8 million in related expenses through year-end. Management stated that it was not party to litigation requiring a probable-loss accrual or disclosure of a possible loss contingency.
- A $0.5 million warranty expense in 2016 related primarily to claims on a specific project that were outside the company’s typical experience; outstanding claims had been satisfied by year-end. The company also recorded $0.7 million of costs for postponed financing of the Statesboro project.
- The company reported annual net losses since inception and negative total cash flow over the recent three-year period excluding IPO proceeds. It expects negative total cash flow in the foreseeable future and may need additional capital to fund growth and expansion.
Investor verification priorities
- Track 2017 revenue against management’s stated decline outlook, especially Reliance-related sales, customer concentration, and replacement demand.
- Confirm cash burn, inventory conversion, capital spending, and continued access to the revolver and other financing.
- Monitor whether Statesboro construction proceeds, the required financing is secured, and BASF’s prepayment conditions are met.
- Review gross-margin trends, selling-price and product-mix changes, manufacturing utilization, and cost reductions.
- Follow the patent litigation, related legal expenses, potential outcomes, and any effects on intellectual-property protection or competition.